Age of Patients in Trials Submitted to the <scp>FDA</scp> Versus Age in Average Patients With Cancer

We found that the age gap between registration trial participants and the general population with the respective tumor type has declined over time, but the age-gap persists, despite guidance issued by the FDA. Efforts to include more representative study participants in clinical trials should be intensified, possibly through greater enforcement through regulatory oversight.